Tuesday September 29
Press Conference: Launch of the EU Screening Week
15.45 -16.30
Berlin Hall
EU Health Commissioner Olivér Várhelyi will be joined by Prof. Francesco Giorgino, Prof. Cecilia Linde, Prof. Vulkan Yumuk and Prof. Chantal Mathieu (who will moderate) during the launch press conference of the EU Screening Week.
The conference will be attended by European and Italian media, and broadcast live on European Commission’s website.
Visit to the EDENT1FI/BR1DGE Screening Booth
16.30-16.45
BR1DGE Booth
At the BR1DGE booth, which will offer screening for type 1 diabetes, Commissioner Várhelyi will have the opportunity to discuss the benefits of early detection of type 1 diabetes and how screening could be implemented in European healthcare systems.
The Commissioner will also meet the EDENT1FI team, who will present this European IHI project focused on the early detection of T1D in children and adolescents, through which over 200,000 children have already been screened.
JACARDI-EUDF Joint Symposium: Reducing the burden of cardiovascular diseases and diabetes in Europe: early evidence from the JACARDI Joint Action
16.45-17.45
Vienna Hall
The symposium will introduce JACARDI and present selected pilot projects on diabetes registries, data, screening and early detection.
Commissioner Várhelyi will be invited to deliver a keynote speech.
Speakers s Agenda
- Introduction
Chantal Mathieu
- EU Screening Week – „Know Your Numbers“: Advancing the EU Safe Hearts Plan Through Early Detection and Screening
Olivér Várhelyi
- Reducing the burden of cardiovascular diseases and diabetes in Europe through the Joint Action JACARDI
Graziano Onder
- JACARDI Pilot Projects
Benedetta Armocida, Astrid Lavens, Flavia Pricci, Olimpia Vincentini, William Leysen
- Conclusion
Stefano Del Prato
Visit to the IDF-E Mobile Screening Unit
17.05-17.15
IDF-EU Screening Unit
At the end of his visit, Commissioner Várhelyi will visit the International Diabetes Federation Europe mobile screening unit, located at the entrance to the conference site, where cardiometabolic screening will be available.
